Anand Badri, MD, FACS Profile
Anand Badri, MD, FACS

@anandbadrimd

Followers
24
Following
250
Media
4
Statuses
46

Robotic and General Urologist @MDLUrology Abington Jefferson Hospital | @TempleUrology @FCUroOnc Trained | @49ers (blood) @Eagles (marriage)

Philadelphia, PA
Joined January 2025
Don't wanna be here? Send us removal request.
@anandbadrimd
Anand Badri, MD, FACS
1 month
Great info to finally share with our patients
@neerajaiims
Neeraj Agarwal, MD, FASCO
1 month
Breaking news from #ESMO25👉Improved OS in high risk biochemical recurrent #ProstateCancer on with ENZA+ADT vs ADT alone, HR: 0.59 (no OS benefit with ENZA monotherapy), 👏wonderful news for our pts👉congrats @SFreedlandMD @nealshore & the team. @OncoAlert @urotoday @PCF_Science
0
0
1
@neerajaiims
Neeraj Agarwal, MD, FASCO
1 month
Breaking news from #ESMO25👉Improved OS in high risk biochemical recurrent #ProstateCancer on with ENZA+ADT vs ADT alone, HR: 0.59 (no OS benefit with ENZA monotherapy), 👏wonderful news for our pts👉congrats @SFreedlandMD @nealshore & the team. @OncoAlert @urotoday @PCF_Science
4
62
125
@zklaassen_md
Zach Klaassen
1 month
Drug Approvals in 🇺🇸 for Prostate Cancer (2010-2025) Go ahead and bookmark this beauty from @PBarataMD @urotoday #ESMO25
1
91
232
@neerajaiims
Neeraj Agarwal, MD, FASCO
1 month
Just in from #ESMO25 Berlin👉Phase III PSMAAddition trial shows that adding ¹⁷⁷Lu-PSMA-617 to ADT + ARPI significantly improved rPFS (HR 0.72; p = 0.002) in PSMA-positive mHSPC, with consistent benefit across subgroups. OS immature. #ProstateCancer @OncoAlert @UroToday
3
39
83
@chavarriagaj
Julian Chavarriaga
1 month
📢 New SOC for MIBC #ESMO25 Dr. Christof Vulsteke presents KEYNOTE-905: 🚫 No cisplatin? No problem. EV+pembro delivers. 👥 n=344 cis-ineligible MIBC (80% renal impairment, 15% ECOG 2) 🔹 EFS HR 0.40 | OS HR 0.50 🔹 pCR: 57.1% vs 8.6% (ITT, non-op = non-responders) 🔹 No ↑
2
34
91
@TonyFelefly
Tony Felefly
2 months
The RAMPP trial has landed ‼️ Congratulations to the authors for this great work!! It compared best systemic therapy + RP (with extended LND) to BST alone for patients with de-novo synchronous oligometastatic PCa, defined as =< 5 bone mets. BST consisted of lifelong ADT. It
7
21
47
@BaldyNFL
Brian Baldinger
2 months
.@49ers @RamsNFL @alfredcollins99 is the HERO; the punch out to stop Kyren at the 1 and the OT stop on 4-1! This game and its outcome come down to 1 yard on 2 occasions #BaldysBreakdowns
36
190
2K
@ToruGotoMD
Toru Goto, MD
3 months
New fellows! Need to know the instrument name firstly!
15
397
2K
@EinsteinUrology
Einstein Urology
3 months
🚨 We’re on Instagram! 🚨 Follow to stay in the loop on the latest research, resident life, and everything happening across our department. https://t.co/XvKH6jjGJE
0
2
8
@EinsteinUrology
Einstein Urology
4 months
We are very excited to welcome Dr. Daniel Eun @md_eun and Dr. Michael Metro @mjmetro1 to the @EinsteinUrology family! Dr. Eun will serve as Clinical Professor of Urology, Fellowship Director of Advanced Robotic Urologic Oncology and Reconstructive Surgery, and Director of the
1
11
96
@AlexSherryMD
Alexander Sherry
4 months
Does the addition of MDT to standard of care continuous ADT improve outcomes for oligomet prostate ca? Happy to share the results of EXTEND evaluating this question alongside PI @ChadTangMD & many others
8
81
189
@anandbadrimd
Anand Badri, MD, FACS
4 months
Great group of residents @EinsteinUrology Welcome!
@md_eun
Daniel D Eun MD
4 months
Embarking on a new chapter of my professional life. Sad to leave my partners and the residents at Temple University after 13 amazing years. I’ve now moved across town to Thomas Jefferson University. I wanted to remember my first case with my new residents @EinsteinUrology!
0
0
1
@md_eun
Daniel D Eun MD
4 months
Embarking on a new chapter of my professional life. Sad to leave my partners and the residents at Temple University after 13 amazing years. I’ve now moved across town to Thomas Jefferson University. I wanted to remember my first case with my new residents @EinsteinUrology!
10
9
149
@anandbadrimd
Anand Badri, MD, FACS
6 months
🤔🤔
@BAUSurology
BAUS
6 months
📰👀Finger test ‘has no role in diagnosing prostate cancer today’ We, alongside @ProstateUK, have united in calling for an end to the routine use of the digital rectal examination, with it no longer being a useful test for #ProstateCancer Via @thetimes: https://t.co/6W7Ra7Jrl1
0
0
0
@anandbadrimd
Anand Badri, MD, FACS
6 months
Fantastic tutorial
@DrSpratticus
Daniel E Spratt
6 months
X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc @theNCI
0
0
0
@SharpFootball
Warren Sharp
6 months
Brock Purdy's 1st yr: 13-4, NFC Champ Loss Brock Purdy's 2nd yr: 12-5, NFC Champ Win Brock Purdy's 3rd yr: #3 in YPA #4 in success rate #5 in EPA/att despite the #2 most injured offense & 57 totals snaps with CMC, Aiyuk, Deebo & Kittle on the field together
46
187
1K
@Dr_Jen_Linehan
Jennifer Linehan, MD
7 months
Need to bring retro adrenalectomy back Into our urology armamentarium MP or SP another great video by @RyanNelson762
@ConnerGanjavi
Conner Ganjavi
7 months
USC’s Marissa Maas presenting on two approaches for SP adrenalectomy in patients with pheochromocytoma!! Fascinating comparison of LFA vs LAA. @oooitsjulz @USC_Urology @mdstifelman @Dr_Jen_Linehan
2
1
14
@anandbadrimd
Anand Badri, MD, FACS
7 months
Last case with ✨ chief resident Tyler Gaines - Retzius Sparing RALP. Won't be doing many of those in Pediatric Urology! Was a privilege being a part of your training You guys have a rockstar coming your way @ChildrensPhila
0
0
6
@anandbadrimd
Anand Badri, MD, FACS
7 months
Any harm in a physical exam? (Some patients come because their PCP specifically doesn't do a DRE)
@rewcastle_john
John Rewcastle, PhD
7 months
Totally agree with @KaraWattsMD that the DRE is dead but good luck convincing the GPs of this….
1
0
0
@NicholasZaorsky
Nicholas Zaorsky, MD MS
8 months
2025 prostate cancer staging from @NCCN and @AJCCancer 8th edition Major change in 2025 NCCN vs prior years: Very high risk disease is now per STAMPEDE criteria (not Hopkins)
5
149
474